Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies by Loni Berkowitz, Cristina Razquin, Cristian Salazar, Fiorella Biancardi, Ramón Estruch, Emilio Ros, Montserrat Fitó, Dolores Corella, Christopher L. Coe, Carol D. Ryff, Miguel Ruiz-Canela, Jordi Salas-Salvado, Daniel Wang, Frank B. Hu, Amy Deik, Miguel A. Martínez-Gonzalez, Attilio Rigotti

Get full text